Cart
0

Hormonal Contraceptive Market by Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, and Transdermal Patches), Hormone (Progestin-only Contraceptive and Combined Hormonal Contraceptive), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Hospitals, Household, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_184574
Pages: 230
Feb 2018 | 1453 Views
 
Author's : Tenzin Kunsel and Garima Chandra
Tables: 134
Charts: 46
 

Hormonal Contraceptive Market Overview:

Hormonal contraceptives are birth control methods, which act on the endocrine system. These methods include the use of hormones that are produced normally by women, such as estrogen and progesterone, to prevent ovulation and in turn pregnancy. However, they do not provide protection against HIV or other sexually transmitted infections. Two types of hormonal contraceptives are available in the market progestin-only contraceptive and combination hormonal contraceptive. These hormonal contraceptives help to prevent pregnancy by suppressing ovulation and thickening of cervical mucus. The global hormonal contraceptive market was valued at $13,924 million in 2016, and is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023.

The major driving factors of the market growth are increase in focus towards family planning and need for preventing unintended pregnancy. The advancement in hormonal contraception with enhanced efficacy and fewer side effects are expected to further boost the market growth. Moreover, health issues associated with teenage pregnancies, increase in awareness towards modern contraception methods, and rise in use of oral pills as a key method to prevent unplanned pregnancy fuel the market growth. However, availability of alternate contraceptive methods, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect the market growth.

Hormone Segment Review

Based on the hormone, the market is bifurcated into progestin-only contraceptive and combined hormonal contraceptive. Combined hormonal contraceptive dominates the market, due to the wide availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.

Get more information on this report : Request Sample Pages

Product Segment Review

Depending on product, the market is categorized into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. Oral contraceptive pill is the dominant segment, as these pills are easily available and have high success rate of up to 99% to prevent pregnancy. However, vaginal rings are expected to grow at the highest rate during the forecast period.

Get more information on this report : Request Sample Pages

Key Geographical Segment

As per region, the hormonal contraceptive market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the hormonal contraceptive market in 2016, and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global hormonal contraceptive market include the Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

Other prominent players in the value chain include Reckitt Benckiser Plc, Warner Chilcott Company, BioSante Pharmaceuticals Inc., HLL Lifecare Limited, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life Care Pvt. Ltd., Cipla Limited, and others.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to hormone, product, age group, end user, and region.
  • In-depth analysis based on geography assists to understand the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Hormonal Contraceptive Market Key Segments:

By Product

  • Oral Contraceptive Pills
  • Injectable Birth Control
  • Emergency Contraceptive Pills
  • Vaginal Rings
  • Transdermal Patches

By Hormone

  • Progestin-only Contraceptive
  • Combined Hormonal Contraceptive

By Age Group

  • 15-24 Years
  • 25-34 Years
  • 35-44 Years
  • Above 44 Years

By End User

  • Hospitals
  • Household
  • Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key Findings

3.2.1. Top Investment Pockets

3.3. Top Player Positioning, 2016
3.4. Porter’s Five Forces Analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Rise in need for preventing unwanted pregnancy
3.5.1.2. Increasing awareness for contraceptives worldwide
3.5.1.3. Rising usage of oral contraceptives as a preferred method to avoid unplanned pregnancy
3.5.1.4. Technological advancements in contraceptive methods
3.5.1.5. Upsurge in government and NGO initiatives promoting contraceptives

3.5.2. Restrains

3.5.2.1. Health risks associated with the use of contraceptive methods
3.5.2.2. Lack of social acceptance

3.5.3. Opportunities

3.5.3.1. Rise in disposable income and demand for healthy life in emerging economies
3.5.3.2. Presence of large unmet contraceptive needs in emerging Asian and African economies

Chapter: 4: HORMONAL CONTRACEPTIVE MARKET BY PRODUCT

4.1. Overview

4.1.1. Market Size and Forecast

4.2. Oral Contraceptive Pills

4.2.1. Key market trends & growth opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country

4.3. Injectable Birth Control

4.3.1. Key market trends & growth opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country

4.4. Emergency Contraceptive Pills

4.4.1. Key market trends & growth opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country

4.5. Vaginal Rings

4.5.1. Key market trends & growth opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Analysis, by Country

4.6. Transdermal Patches

4.6.1. Key market trends & growth opportunities
4.6.2. Market Size and Forecast
4.6.3. Market Analysis, by Country

Chapter: 5: HORMONAL CONTRACEPTIVE MARKET BY HORMONE

5.1. Overview

5.1.1. Market Size and Forecast

5.2. Progestin-only Contraceptive

5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country

5.3. Combined Hormonal Contraceptive

5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country

Chapter: 6: HORMONAL CONTRACEPTIVE MARKET BY AGE GROUP

6.1. Overview

6.1.1. Market Size and Forecast

6.2. 15-24 years

6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country

6.3. 25-34 years

6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country

6.4. 35-44 years

6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country

6.5. Above 44 years

6.5.1. Market Size and Forecast
6.5.2. Market Analysis, by Country

Chapter: 7: HORMONAL CONTRACEPTIVE MARKET BY END USERS

7.1. Overview

7.1.1. Market Size and Forecast

7.2. Hospitals

7.2.1. Market Size and Forecast
7.2.2. Market Analysis, by Country

7.3. Household

7.3.1. Market Size and Forecast
7.3.2. Market Analysis, by Country

7.4. Clinics

7.4.1. Market Size and Forecast
7.4.2. Market Analysis, by Country

Chapter: 8: HORMONAL CONTRACEPTIVE MARKET BY GEOGRAPHY

8.1. Overview

8.1.1. Market Size and Forecast

8.2. North America

8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, by Product Type
8.2.3. Market Size and Forecast, by Hormone
8.2.4. Market Size and Forecast, by Age Group
8.2.5. Market Size and Forecast, by End Users
8.2.6. Market Size and Forecast, by Country

8.2.6.1. U.S. Market Size and Forecast, by Product Type
8.2.6.2. U.S. Market Size and Forecast, by Hormone
8.2.6.3. U.S. Market Size and Forecast, by Age Group
8.2.6.4. U.S. Market Size and Forecast, by End Users
8.2.6.5. Canada Market Size and Forecast, by Product Type
8.2.6.6. Canada Market Size and Forecast, by Hormone
8.2.6.7. Canada Market Size and Forecast, by Age Group
8.2.6.8. Canada Market Size and Forecast, by End Users
8.2.6.9. Mexico Market Size and Forecast, by Product Type
8.2.6.10. Mexico Market Size and Forecast, by Hormone
8.2.6.11. Mexico Market Size and Forecast, by Age Group
8.2.6.12. Mexico Market Size and Forecast, by End Users

8.3. Europe

8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, by Product Type
8.3.3. Market Size and Forecast, by Hormone
8.3.4. Market Size and Forecast, by Age Group
8.3.5. Market Size and Forecast, by End Users
8.3.6. Market Size and Forecast, by Country

8.3.6.1. Germany Market Size and Forecast, by Product Type
8.3.6.2. Germany Market Size and Forecast, by Hormone
8.3.6.3. Germany Market Size and Forecast, by Age Group
8.3.6.4. Germany Market Size and Forecast, by End Users
8.3.6.5. France Market Size and Forecast, by Product Type
8.3.6.6. France Market Size and Forecast, by Hormone
8.3.6.7. France Market Size and Forecast, by Age Group
8.3.6.8. France Market Size and Forecast, by End Users
8.3.6.9. UK Market Size and Forecast, by Product Type
8.3.6.10. UK Market Size and Forecast, by Hormone
8.3.6.11. UK Market Size and Forecast, by Age Group
8.3.6.12. UK Market Size and Forecast, by End Users
8.3.6.13. Italy Market Size and Forecast, by Product Type
8.3.6.14. Italy Market Size and Forecast, by Hormone
8.3.6.15. Italy Market Size and Forecast, by Age Group
8.3.6.16. Italy Market Size and Forecast, by End Users
8.3.6.17. Spain Market Size and Forecast, by Product Type
8.3.6.18. Spain Market Size and Forecast, by Hormone
8.3.6.19. Spain Market Size and Forecast, by Age Group
8.3.6.20. Spain Market Size and Forecast, by End Users
8.3.6.21. Rest of Europe Market Size and Forecast, by Product Type
8.3.6.22. Rest of Europe Market Size and Forecast, by Hormone
8.3.6.23. Rest of Europe Market Size and Forecast, by Age Group
8.3.6.24. Rest of Europe Market Size and Forecast, by End Users

8.4. Asia-Pacific

8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, by Product Type
8.4.3. Market Size and Forecast, by Hormone
8.4.4. Market Size and Forecast, by Age Group
8.4.5. Market Size and Forecast, by End Users
8.4.6. Market Size and Forecast, by Country

8.4.6.1. Japan Market Size and Forecast, by Product Type
8.4.6.2. Japan Market Size and Forecast, by Hormone
8.4.6.3. Japan Market Size and Forecast, by Age Group
8.4.6.4. Japan Market Size and Forecast, by End Users
8.4.6.5. China Market Size and Forecast, by Product Type
8.4.6.6. China Market Size and Forecast, by Hormone
8.4.6.7. China Market Size and Forecast, by Age Group
8.4.6.8. China Market Size and Forecast, by End Users
8.4.6.9. Australia Market Size and Forecast, by Product Type
8.4.6.10. Australia Market Size and Forecast, by Hormone
8.4.6.11. Australia Market Size and Forecast, by Age Group
8.4.6.12. Australia Market Size and Forecast, by End Users
8.4.6.13. India Market Size and Forecast, by Product Type
8.4.6.14. India Market Size and Forecast, by Hormone
8.4.6.15. India Market Size and Forecast, by Age Group
8.4.6.16. India Market Size and Forecast, by End Users
8.4.6.17. South Korea Market Size and Forecast, by Product Type
8.4.6.18. South Korea Market Size and Forecast, by Hormone
8.4.6.19. South Korea Market Size and Forecast, by Age Group
8.4.6.20. South Korea Market Size and Forecast, by End Users
8.4.6.21. Rest of Asia-Pacific Market Size and Forecast, by Product Type
8.4.6.22. Rest of Asia-Pacific Market Size and Forecast, by Hormone
8.4.6.23. Rest of Asia-Pacific Market Size and Forecast, by Age Group
8.4.6.24. Rest of Asia-Pacific Market Size and Forecast, by End Users

8.5. LAMEA

8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, by Product Type
8.5.3. Market Size and Forecast, by Hormone
8.5.4. Market Size and Forecast, by Age Group
8.5.5. Market Size and Forecast, by End Users
8.5.6. Market Size and Forecast, by Country

8.5.6.1. Brazil Market Size and Forecast, by Product Type
8.5.6.2. Brazil Market Size and Forecast, by Hormone
8.5.6.3. Brazil Market Size and Forecast, by Age Group
8.5.6.4. Brazil Market Size and Forecast, by End Users
8.5.6.5. Saudi Arabia Market Size and Forecast, by Product Type
8.5.6.6. Saudi Arabia Market Size and Forecast, by Hormone
8.5.6.7. Saudi Arabia Market Size and Forecast, by Age Group
8.5.6.8. Saudi Arabia Market Size and Forecast, by End Users
8.5.6.9. South Africa Market Size and Forecast, by Product Type
8.5.6.10. South Africa Market Size and Forecast, by Hormone
8.5.6.11. South Africa Market Size and Forecast, by Age Group
8.5.6.12. South Africa Market Size and Forecast, by End Users
8.5.6.13. Rest of LAMEA Market Size and Forecast, by Product Type
8.5.6.14. Rest of LAMEA Market Size and Forecast, by Hormone
8.5.6.15. Rest of LAMEA Market Size and Forecast, by Age Group
8.5.6.16. Rest of LAMEA Market Size and Forecast, by End Users

Chapter: 9: COMPANY PROFILES

9.1. Ansell Limited

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance

9.2. Bayer AG

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. Church & Dwight Co. Inc.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance

9.4. Johnson & Johnson

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance

9.5. Mayer Laboratories Inc.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments

9.6. Merck & Co. Inc.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance

9.7. Mylan N.V.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. Pfizer Inc.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. Teva Pharmaceutical Industries Ltd.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. The Female Health Company

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Business performance

LIST OF TABLES

TABLE 01. GLOBAL HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 02. ORAL HORMONAL CONTRACEPTIVE PILLS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 03. INJECTABLE HORMONAL CONTRACEPTIVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 04. EMERGENCY HORMONAL CONTRACEPTIVE PILLS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 05. VAGINAL RINGS HORMONAL CONTRACEPTIVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 06. TRANSDERMAL PATCHES HORMONAL CONTRACEPTIVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 08. PROGESTIN-ONLY CONTRACEPTIVE HORMONAL CONTRACEPTIVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 09. COMBINED HORMONAL CONTRACEPTIVE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 11. HORMONAL CONTRACEPTIVE MARKET FOR 15-24 YEARS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. HORMONAL CONTRACEPTIVE MARKET, FOR 25-34 YEARS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. HORMONAL CONTRACEPTIVE SOFTWARE MARKET, FOR 35-44 YEARS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. HORMONAL CONTRACEPTIVE MARKET, FOR ABOVE 44 YEARS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 16. HORMONAL CONTRACEPTIVE MARKET BY HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. HORMONAL CONTRACEPTIVE MARKET BY HOUSEHOLD, BY REGION, 2016-2023 ($MILLION)
TABLE 18. HORMONAL CONTRACEPTIVE MARKET BY CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 19. HORMONAL CONTRACEPTIVE MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. U.S. HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 26. U.S. HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 27. U.S. HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 28. U.S. HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 29. CANADA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 30. CANADA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 31. CANADA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 32. CANADA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 33. MEXICO HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 34. MEXICO HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 35. MEXICO HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 36. MEXICO HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 37. EUROPE HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. EUROPE HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 39. EUROPE HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 40. EUROPE HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 41. EUROPE HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. GERMANY HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 43. GERMANY HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 44. GERMANY HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 45. GERMANY HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 46. FRANCE HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 47. FRANCE HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 48. FRANCE HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 49. FRANCE HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 50. UK HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 51. UK HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 52. UK HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 53. UK HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 54. ITALY HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 55. ITALY HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 56. ITALY HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 57. ITALY HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 58. SPAIN HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 59. SPAIN HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 60. SPAIN HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 61. SPAIN HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 62. REST OF EUROPE HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 63. REST OF EUROPE HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 64. REST OF EUROPE HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 65. REST OF EUROPE HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 66. ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 67. ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 68. ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 70. ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 71. JAPAN HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 72. JAPAN HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 73. JAPAN HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 74. JAPAN HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 75. CHINA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 76. CHINA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 77. CHINA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 78. CHINA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 79. AUSTRALIA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 80. AUSTRALIA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 81. AUSTRALIA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 82. AUSTRALIA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 83. INDIA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 84. INDIA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 85. INDIA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 86. INDIA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 87. SOUTH KOREA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 88. SOUTH KOREA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 89. SOUTH KOREA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 90. SOUTH KOREA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 95. LAMEA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 96. LAMEA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 97. LAMEA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 98. LAMEA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 99. LAMEA HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 100. BRAZIL HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 101. BRAZIL HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 102. BRAZIL HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 103. BRAZIL HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 104. SAUDI ARABIA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 105. SAUDI ARABIA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 106. SAUDI ARABIA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 107. SAUDI ARABIA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 108. SOUTH AFRICA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 109. SOUTH AFRICA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 110. SOUTH AFRICA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 111. SOUTH AFRICA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 112. REST OF LAMEA HORMONAL CONTRACEPTIVE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 113. REST OF LAMEA HORMONAL CONTRACEPTIVE MARKET, BY HORMONE, 2016-2023 ($MILLION)
TABLE 114. REST OF LAMEA HORMONAL CONTRACEPTIVE MARKET, BY AGE GROUP, 2016-2023 ($MILLION)
TABLE 115. REST OF LAMEA HORMONAL CONTRACEPTIVE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 116. ANSELL: COMPANY SNAPSHOT
TABLE 117. ANSELL: OPERATING SEGMENTS
TABLE 118. BAYER: COMPANY SNAPSHOT
TABLE 119. BAYER: OPERATING SEGMENTS
TABLE 120. CHURCH & DWIGHT: COMPANY SNAPSHOT
TABLE 121. CHURCH & DWIGHT: OPERATING SEGMENTS
TABLE 122. J&J: COMPANY SNAPSHOT
TABLE 123. J&J: OPERATING SEGMENTS
TABLE 124. MAYER: COMPANY SNAPSHOT
TABLE 125. MAYER: OPERATING PRODUCT CATEGORIES
TABLE 126. MERCK: COMPANY SNAPSHOT
TABLE 127. MERCK: OPERATING SEGMENTS
TABLE 128. MYLAN: COMPANY SNAPSHOT
TABLE 129. MYLAN: OPERATING SEGMENTS
TABLE 130. PFIZER: COMPANY SNAPSHOT
TABLE 131. PFIZER: OPERATING SEGMENTS
TABLE 132. TEVA: COMPANY SNAPSHOT
TABLE 133. TEVA: OPERATING SEGMENTS
TABLE 134. THE FEMALE HEALTH COMPANY: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01. GLOBAL HORMONAL CONTRACEPTIVE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2016
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. HIGH THREAT OF SUBSTITUTION
FIGURE 08. HIGH COMPETITIVE RIVALRY
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF ORAL HORMONAL CONTRACEPTIVE PILLS MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF INJECTABLE HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF EMERGENCY HORMONAL CONTRACEPTIVE PILLS MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VAGINAL RINGS HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TRANSDERMAL PATCHES HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROGESTIN-ONLY CONTRACEPTIVE HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF COMBINED HORMONAL CONTRACEPTIVE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE MARKET FOR 15-24 YEARS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE MARKET, FOR 25-34 YEARS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE SOFTWARE MARKET, FOR 35-44 YEARS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE MARKET, FOR ABOVE 44 YEARS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE MARKET BY HOSPITALS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE MARKET BY HOUSEHOLD, BY COUNTRY, 2016 & 2023 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HORMONAL CONTRACEPTIVE MARKET BY CLINICS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 23. ANSELL: NET SALES, 2015-2017 ($MILLION)
FIGURE 24. ANSELL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25. ANSELL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26. BAYER: NET SALES, 2015-2017 ($MILLION)
FIGURE 27. BAYER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28. BAYER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. CHURCH & DWIGHT: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. CHURCH & DWIGHT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 31. J&J: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. MERCK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 36. MERCK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 37. MYLAN: NET SALES, 2015-2017 ($MILLION)
FIGURE 38. MYLAN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 39. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. PFIZER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 41. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 42. TEVA: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. TEVA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44. TEVA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 45. THE FEMALE HEALTH COMPANY: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. THE FEMALE HEALTH COMPANY: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

 

Hormonal contraceptives are used to prevent pregnancy by causing hormonal changes in the body, making it unfavorable for fertilization. The government initiative to spread awareness regarding the benefits of family planning & birth control and prevention of unplanned pregnancy are expected to play a major role in the growth of the hormonal contraceptive market. The advancement in hormonal contraceptive technologies and methods for the development of products with better efficiency & fewer side effects and increase in use of contraceptive drug & devices further boost the market growth. Hormonal contraceptives have piqued the interest of healthcare providers due to the benefits offered by these drugs and devices along with higher efficiency to prevent unwanted pregnancy. However, lack of reimbursement policies and high cost of new contraceptive devices hamper the market growth. Currently, oral contraceptive or pill segment garner the largest revenue share in the hormonal contraceptives market, followed by vaginal rings.

Household users accounted for a significant share of end users in the contraceptive market, due to the use of user-friendly hormonal contraceptive methods such as pills, rings, and patches. Contraceptive manufacturers have focused on marketing novel contraceptives for household users through various media such as television, internet, and others.

The use of hormonal contraceptive system is highest in North America, particularly in the U.S., owing to rise in awareness about the benefits of using hormonal contraceptive and favorable regulatory scenario. Although the use of hormonal contraceptive in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase due to presence of populace countries such as India and China, where there is higher need to control the growing population.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Hormonal Contraceptive Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo